FLT3LG and neoplasm: Indeed, systemic treatment with Flt3L, leading to supraphysiological Flt3L levels, resulted in the expansion of cDCs and pDCs in the TME of mouse melanoma and reduced tumor growth when used in combination therapies (5, 6).